Literature DB >> 19377080

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo.

Silvia Heringer-Walther1, Klaus Eckert, Sarah-Mai Schumacher, Lutz Uharek, Annika Wulf-Goldenberg, Florian Gembardt, Iduna Fichtner, Heinz-Peter Schultheiss, Kathy Rodgers, Thomas Walther.   

Abstract

Effects of angiotensin (Ang)-(1-7), an AngII metabolite, on bone marrow-derived hematopoietic cells were studied. We identified Ang-(1-7) to stimulate proliferation of human CD34(+) and mononuclear cells in vitro. Under in vivo conditions, we monitored proliferation and differentiation of human cord blood mononuclear cells in NOD/SCID mice. Ang-(1-7) stimulated differentially human cells in bone marrow and accumulated them in the spleen. The number of HLA-I(+) and CD34(+) cells in the bone marrow was increased 42-fold and 600-fold, respectively. These results indicate a decisive impact of Ang-(1-7) on hematopoiesis and its promising therapeutic potential in diseases requiring progenitor stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377080      PMCID: PMC2688578          DOI: 10.3324/haematol.2008.000034

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  10 in total

1.  Effects of angiotensin II receptor signaling during skin wound healing.

Authors:  Hikaru Takeda; Yohtaro Katagata; Yutaka Hozumi; Shigeo Kondo
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 2.  Angiotensin receptors.

Authors:  T Unger; O Chung; T Csikos; J Culman; S Gallinat; P Gohlke; S Höhle; S Meffert; M Stoll; U Stroth; Y Z Zhu
Journal:  J Hypertens Suppl       Date:  1996-12

3.  Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.

Authors:  Norifumi Urao; Mitsuhiko Okigaki; Hiroyuki Yamada; Yasushi Aadachi; Kuniharu Matsuno; Akihiro Matsui; Shinsaku Matsunaga; Kento Tateishi; Tetsuya Nomura; Tomosaburo Takahashi; Tetsuya Tatsumi; Hiroaki Matsubara
Journal:  Circ Res       Date:  2006-04-27       Impact factor: 17.367

4.  Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Authors:  K E Rodgers; S Xiong; R Steer; G S diZerega
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

Review 5.  Angiotensin I, angiotensin II and their biologically active peptides.

Authors:  Carlos M Ferrario
Journal:  J Hypertens       Date:  2002-05       Impact factor: 4.844

6.  Accelerated recovery from irradiation injury by angiotensin peptides.

Authors:  Kathleen E Rodgers; Shiquin Xiong; Gere S diZerega
Journal:  Cancer Chemother Pharmacol       Date:  2002-03-07       Impact factor: 3.333

7.  Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.

Authors:  Kathleen Rodgers; Shiquin Xiong; Gere S DiZerega
Journal:  Cancer Chemother Pharmacol       Date:  2002-12-19       Impact factor: 3.333

8.  Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.

Authors:  Dolph D Ellefson; Gere S diZerega; Theresa Espinoza; Norma Roda; Sonia Maldonado; Kathleen E Rodgers
Journal:  Cancer Chemother Pharmacol       Date:  2003-10-16       Impact factor: 3.333

9.  Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells.

Authors:  Anantha Vijay R Santhanam; Livius V d'Uscio; Timothy E Peterson; Zvonimir S Katusic
Journal:  Peptides       Date:  2008-03-25       Impact factor: 3.750

10.  Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells.

Authors:  Elias T Zambidis; Tea Soon Park; Wayne Yu; Ada Tam; Michal Levine; Xuan Yuan; Marina Pryzhkova; Bruno Péault
Journal:  Blood       Date:  2008-08-26       Impact factor: 22.113

  10 in total
  23 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

2.  Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7).

Authors:  Christian Meinert; Florian Gembardt; Ilka Böhme; Anja Tetzner; Thomas Wieland; Barry Greenberg; Thomas Walther
Journal:  J Proteomics       Date:  2015-09-24       Impact factor: 4.044

3.  A role for the renin-angiotensin system in hematopoiesis.

Authors:  Tea Soon Park; Elias T Zambidis
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

4.  Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.

Authors:  Yanfei Qi; Juan Zhang; Colleen T Cole-Jeffrey; Vinayak Shenoy; Andrew Espejo; Mina Hanna; Chunjuan Song; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

Review 5.  New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.

Authors:  Carlos M Ferrario
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

Review 6.  The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis.

Authors:  Xiao Z Shen; Kenneth E Bernstein
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

7.  Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.

Authors:  N M Mordwinkin; C J Meeks; S S Jadhav; T Espinoza; N Roda; G S diZerega; S G Louie; K E Rodgers
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

8.  ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.

Authors:  Neha Singh; Shrinidh Joshi; Lirong Guo; Matthew B Baker; Yan Li; Ronald K Castellano; Mohan K Raizada; Yagna P R Jarajapu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

9.  A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.

Authors:  Amee J George; Brooke W Purdue; Cathryn M Gould; Daniel W Thomas; Yanny Handoko; Hongwei Qian; Gregory A Quaife-Ryan; Kylie A Morgan; Kaylene J Simpson; Walter G Thomas; Ross D Hannan
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

Review 10.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.